Assets: Royalty interests in thirty-eight approved and marketed products and two products in clinical trials and/or under review with the United States Food and Drug Administration (“FDA”) and/or the European Medicines Agency ("EMA").
Main Office: 110 East 59th Street
33rd Floor New York, NY 10022
Contact Information:
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
tel: (212) 883-0200
